Beka Solomon, PhD
Beka Solomon is a professor at Tel Aviv University and the former chair for biotechnology of neurodegenerative diseases. She joined Tel Aviv University in 1979 following her postdoctoral studies and training at Harvard Medical School and Brigham and Women’s Hospital. Solomon has spearheaded many advances in Alzheimer’s disease, three of which have been licensed to Wyeth and Elan in a landmark deal. Solomon earned her doctorate from the Weizmann Institute of Science, Rehovot, Israel.
Solomon received the Zenith Award from the Alzheimer’s Association in 2002, was named to Scientific American’s “SciAm 50” list of leading innovative scientists for her work with phage to disaggregate Aβ plaque in 2007, and has the support of the Alzheimer’s Drug Discovery Foundation for her research in Alzheimer’s vaccines.